Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPIC
1951
DELISTED
TPI Composites
TPIC
| $20.3M | ﹤0.01% |
601,071
+14,366
| +2% | +$564K |
|
1952
S&T Bancorp
STBA
$1.82B
| $20.2M | ﹤0.01% |
686,224
+2,785
| +0.4% | +$82.1K |
|
|
UMH
1953
UMH Properties
UMH
$1.42B
| $20.2M | ﹤0.01% |
880,441
+44,434
| +5% | +$1.04M |
|
|
AIV
1954
Aimco
AIV
$379M
| $20.2M | ﹤0.01% |
2,942,607
+37,878
| +1% | +$261K |
|
1955
Delek US
DK
$4.18B
| $20.1M | ﹤0.01% |
1,120,360
-35,364
| -3% | -$602K |
|
1956
Marten Transport
MRTN
$1.24B
| $20.1M | ﹤0.01% |
1,282,272
+66,430
| +5% | +$1.04M |
|
1957
Standex International
SXI
$3.97B
| $20.1M | ﹤0.01% |
202,901
+187
| +0.1% | +$17.8K |
|
1958
Imperial Oil
IMO
$64B
| $20.1M | ﹤0.01% |
638,995
+59,717
| +10% | +$1.65M |
|
1959
Southern Copper
SCCO
$158B
| $20M | ﹤0.01% |
391,572
+37,293
| +11% | +$2.13M |
|
1960
Safety Insurance
SAFT
$1.52B
| $19.9M | ﹤0.01% |
251,710
-181
| -0.1% | -$14.3K |
|
1961
Veeco
VECO
$3.28B
| $19.9M | ﹤0.01% |
894,855
+30,564
| +4% | +$681K |
|
1962
Universal Corp
UVV
$1.12B
| $19.9M | ﹤0.01% |
411,028
+142
| +0% | +$7.21K |
|
1963
BellRing Brands
BRBR
$1.28B
| $19.8M | ﹤0.01% |
643,885
-1,563
| -0.2% | -$50K |
|
|
EVOP
1964
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $19.8M | ﹤0.01% |
835,922
+7,508
| +0.9% | +$199K |
|
|
SGMO
1965
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $19.8M | ﹤0.01% |
2,195,343
+134,807
| +7% | +$1.33M |
|
1966
Ichor Holdings
ICHR
$2.67B
| $19.8M | ﹤0.01% |
480,774
+3,173
| +0.7% | +$145K |
|
|
GBIO
1967
DELISTED
Generation Bio
GBIO
| $19.7M | ﹤0.01% |
78,664
+22,377
| +40% | +$5.36M |
|
1968
BioLife Solutions
BLFS
$1.72B
| $19.7M | ﹤0.01% |
465,727
-22,279
| -5% | -$1.07M |
|
1969
Buckle
BKE
$2.31B
| $19.6M | ﹤0.01% |
495,431
+3,955
| +0.8% | +$169K |
|
1970
Cerus
CERS
$572M
| $19.6M | ﹤0.01% |
3,217,253
+210,867
| +7% | +$1.23M |
|
1971
Archrock
AROC
$5.85B
| $19.6M | ﹤0.01% |
2,373,068
+90,475
| +4% | +$728K |
|
1972
Transocean
RIG
$6.39B
| $19.6M | ﹤0.01% |
5,163,116
+120,643
| +2% | +$439K |
|
1973
Brookdale Senior Living
BKD
$3B
| $19.5M | ﹤0.01% |
3,098,643
-181,664
| -6% | -$1.3M |
|
1974
Usana Health Sciences
USNA
$252M
| $19.5M | ﹤0.01% |
211,699
-6,121
| -3% | -$589K |
|
|
TSP
1975
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $19.5M | ﹤0.01% |
524,876
-1,200
| -0.2% | -$50.6K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.